Anti-Infectives: Pharmacoepidemiology and Clinical Pharmacology
A special issue of Pharmacoepidemiology (ISSN 2813-0618).
Deadline for manuscript submissions: closed (31 July 2024) | Viewed by 8214
Special Issue Editors
Interests: infectious diseases, and resistance to antimicrobial resistance; antimicrobial stewardship; clinical pharmacy; evidence-based practice; outcomes research; resistance; pharmacy
Special Issue Information
Dear Colleagues,
Antibiotics are life-saving medications. Since the inception of the first antibiotic, there have been continuous and growing complexities associated with the application and development of anti-infective agents, much of which is owed to antimicrobial resistance. The pharmacoepidemiology and pharmacovigilance of various antimicrobials tend to differ between institutions, patient populations, and countries due to an innumerable number of factors. However, there is one constant: the ever-changing nature of microorganisms influenced by antimicrobials. This Special Issue aims to collect articles that consider and foreground various aspects of anti-infectives, including resistance, adverse events, epidemiology, disparities in healthcare, health policy, and best practices. As knowledge regarding antimicrobials is further disseminated, novel frameworks can be developed and compared across various institutions or communities.
Dr. Lee Nguyen
Dr. Jason Yamaki
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacoepidemiology is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.